Global Proton Therapy Market will surpass US$ 18 Billion by 2018
Access full Research: https://www.renub.com/global-proton-therapy-market-and-forecast-12-countries-market-data-patients-treated-at-proton-therapy-centers-reimbursement-policies-1073-p.php Global Proton Therapy market will surpass US$ 18 Billion by 2018. According to Renub research analysis, the global proton therapy market will be growing at a rapid pace due to rising number of proton therapy center across the world. In addition, there are number of proton therapy center in construction and planning phase in several countries like China, United Kingdom, Germany, France, Japan, United States, Korea and Switzerland. United States is hub of proton therapy that holds more than 40 percent proton therapy center till 2018. United Kingdom is best known for healthcare facilities, but number of proton therapy center is very few as per the demand. So patient from United Kingdom has to go United States for treatment. According to our research, United Kingdom is likely to launch 5 most advanced multi-room proton therapy center owned by NHS and Private Players during the forecast period. Request a free sample copy of the report: https://www.renub.com/contactus.php Europe will significantly drive Global Proton Therapy Market in the forecast period due to Rising Number of Proton Therapy Center In this report, we provide special chapter about Europe Proton Therapy that covers 8 countries of Europe – United Kingdom, Switzerland, Russia, Germany, France, Italy, Sweden and Poland. This report covers detailed investigation of proton therapy by market & forecast by each countries, volume of patient treated and forecast by each country, volume of patients treated by each proton therapy center located in the country. In addition we have also covered the number of proton therapy center in operational state, under-construction phase and planning stage by each country. These reports also talk about dimension and structure of reimbursement policies.
★
★
★
★
★
226 views • 21 slides
